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Abstract: NadR is a bifunctional enzyme that converts nicotinamide riboside (NR) into 
nicotinamide mononucleotide (NMN), which is then converted into nicotinamide adenine 
dinucleotide (NAD). Although a crystal structure of the enzyme from the Gram-negative bacterium 
Haemophilus influenzae is known, structural understanding of its catalytic mechanism remains 
unclear. Here, we purified the NadR enzyme from Lactococcus lactis and established an assay to 
determine the combined activity of this bifunctional enzyme. The conversion of NR into NAD 
showed hyperbolic dependence on the NR concentration, but sigmoidal dependence on the ATP 
concentration. The apparent cooperativity for ATP may be explained because both reactions 
catalyzed by the bifunctional enzyme (phosphorylation of NR and adenylation of NMN) require 
ATP. The conversion of NMN into NAD followed simple Michaelis-Menten kinetics for NMN, but 
again with the sigmoidal dependence on the ATP concentration. In this case, the apparent 
cooperativity is unexpected since only a single ATP is used in the NMN adenylyltransferase 
catalyzed reaction. To determine the possible structural determinants of such cooperativity, we 
solved the crystal structure of NadR from L. lactis (NadRLl). Co-crystallization with NAD, NR, 
NMN, ATP, and AMP-PNP revealed a ‘sink’ for adenine nucleotides in a location between two 
domains. This sink could be a regulatory site, or it may facilitate the channeling of substrates 
between the two domains. 
Keywords: Nicotinamide riboside; vitamins; NAD; NMN; NadR 
 
1. Introduction 
Nicotinamide riboside (NR, a form of Vitamin B3) is one of the common precursors for 
biosynthesis of nicotinamide adenine dinucleotide (NAD) [1,2]. In some prokaryotes, NR is taken up 
by PnuC membrane transporters via a facilitated-diffusion transport mechanism [3–8]. Recently a 
high-resolution crystal structure of PnuC from Neisseria mucosa with a bound NR molecule was 
reported [9,10]. The substrate specificity of the PnuC protein for NR has been confirmed for 
homologs from Escherichia coli, Haemophilus influenzae, Haemophilus parainfluenzae, Salmonella 
typhimurium, and Neisseria mucosa [5,6,10–12]. In some organisms, such as Clostridium thermocellum 
and Nostoc punctiforme, the pnuC gene clusters with nadR [1,2]. NadR converts NR into nicotinamide 
mononucleotide (NMN) and subsequently into NAD [13]. NadR was initially thought to have a 
transport function too, which was later found to be incorrect [14]. Instead, the conversion of NR into 
NMN and subsequently into NAD [14] by NadR leads to metabolic substrate trapping of NR in the 
cytoplasm as phosphorylation prevents the efflux via PnuC. NadR is present in many Gram-positive 
and Gram-negative bacteria [15], and in some organisms, the protein also senses the internal NAD 
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pool in order to repress essential genes for NAD biosynthesis and to regulate transport via PnuC in 
response to cellular NAD levels [16–19]. In Enterobacteria, the gene encoding PnuC is located in an 
operon with the gene for the NAD biosynthesis protein NadA (quinolinate synthase), and the 
expression of this gene cluster is regulated by NadR. In this case the bifunctional NadR enzyme acts 
additionally as a transcription factor due to the presence of an N-terminal DNA binding motif [15].  
A structure of NadR from Haemophilus influenzae (NadRHi) has been determined and revealed 
that the protein consists of two distinct domains separated by a short flexible linker, probably 
necessary for the movement of domains to perform both enzymatic steps [20–22]. Each domain has a 
specific catalytic activity: the N-terminal domain possesses an NMN adenylyltransferase (EC 2.7.7.1) 
activity (NMNAT domain), and the C-terminal domain is a ribosylnicotinamide kinase (EC 2.7.1.22) 
(RNK domain) (Supplementary Figure S1). Structurally the NMNAT domain is similar to archaeal 
NMNAT, whereas the RNK domain is similar to yeast thymidylate kinase [22]. For the NadR gene of 
E. coli, it has been shown experimentally that the NMNAT domain is indeed responsible for the 
transfer of the AMP moiety from ATP to NMN [23]. A crystal structure of the E. coli NMNAT 
domain of NadR with NAD bound has been reported [24]. NadR from S. typhimurium has been 
shown to be a NAD dependent repressor for several genes [nadB, nadA-pnuC, and pncB] involved in 
de novo biosynthesis of NAD and niacin salvage [16,25–29]. Additionally, there are some suggestions 
that NadR interacts with the PnuC membrane protein during transport of NR molecule [30]; 
however, so far, there is no experimental evidence for such direct interaction.  
The NadR enzyme from the Gram-negative bacterium H. influenzae is biochemically and 
structurally well characterized. Here, we report the first structural and biochemical characterization 
of a NadR protein from a Gram-positive bacterium (Lactococcus lactis), and compare it with the 
Gram-negative ortholog.  
2. Results 
2.1. Multiple Sequence Alignment of NadR 
To compare the NadRLl protein sequence with the homologous proteins from different 
organisms, we did a multiple sequence alignment [31]. In contrast to many homologs, NadRLl lacks 
the N-terminal DNA binding domain (Figure 1, corresponding to amino acid residues 1 to 59 in the 
H. influenza sequence, also known as HTH domain responsible for DNA binding). NadR protein 
sequences are more conserved among Gram-negative bacteria (54.7% sequence identity between 
NadREc (NadR protein from E. coli) and NadRSt (NadR protein from S.typhimurium)) compared to 
NadR proteins from Gram-positive bacteria (26.4% sequence identity between NadRLl and NadRBs 
(NadR protein Bacillus sp). The sequence identity between NadREc and NadRLl is about 23.5%. 
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Figure 1. Multiple sequence alignment of NadR proteins from selected organisms. The amino acid 
residues are colored based on conservation, amino acids colored red are similar in more than 50% of 
the aligned NadR sequences. The amino acid residues in the red columns are conserved in all aligned 
NadR sequences. Organisms’ names: L. lactis (Lactococcus lactis), M. tuberculosis (Mycobacterium 
tuberculosis), Bacillus sp. (Bacillus sp.), S. typhimurium (Salmonella typhimurium), E. coli (Escherichia coli), 
S. flexneri (Shigella flexneri), S. plymutica (Serretia plymutica), Y. frederiksenii (Yersenia frederiksenii), H. 
influenzae (Haemophilus influenzae), and H. parassuis (Haemophilus parassuis). The bars on top show the 
locations of the three distinct domains of NadR proteins. The blue bars below the alignment indicate 
NAD binding residues, the red bars walker A and walker B motifs, and the pink bars are the 
phosphate-binding sites. 
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2.2. Substrate Specificity of NadR 
We performed isothermal titration calorimetry (ITC) measurements to study substrate binding 
to NadRLl. We tested the binding of NR, NMN, NAD, ATP, and AMP-PNP 
(adenylyl-imidodiphosphate, an extremely slowly-hydrolyzable ATP analog). The measured 
binding affinities for Mg2+-complexed ATP and AMP-PNP are 63 µM and 13 µM, respectively (Table 
1). Surprisingly, no binding for the nicotinamide nucleotide substrates in the presence and absence 
of ATP and AMP-PNP was detected. One possible explanation is that these substrates were bound 
very tightly to the protein during protein production in E. coli, and stayed attached during the 
protein purification steps. To circumvent this potential problem, we tried different 
unfolding-refolding protocols (including the use of urea and guanidium chloride up to a four molar 
concentration) of the purified protein in the absence of any substrate. However, upon treatment with 
denaturants, the protein stability decreased, and the protein could not be refolded (inferred from 
subsequent size exclusion chromatography). We also tried to perform mass-spectrometry on the 
purified protein in solution and on NadRLl protein crystals to determine whether there were tightly 
bound nucleotides; however, the results were inconclusive (although in the protein crystals we 
detected some traces of NR and NMN).  
Table 1. Substrate binding studied by isothermal titration calorimetry (ITC) with NadR protein from 
L. lactis. 
Substrate Dissociation Constant–KD (µM) 
ATP 63 ± 1 
AMP-PNP 13 ± 1 
NR No Binding 
NMN No Binding 
NAD No Binding 
Nicotinamide No Binding 
Nicotinic acid No Binding 
The error represents the upper and lower values from two measurements. 
2.3. Steady State Kinetics 
To investigate the kinetics of the NadRLl-catalyzed reaction, we used a lactate dehydrogenase 
(LDH) coupled assay. LDH was used to reduce the product NAD of the NadRLl- catalyzed reaction 
to NADH, the concentration of which can be measured by the absorption at 340 nm. In these 
measurements, we ensured that the LDH-catalyzed reaction was not rate-limiting. The NadRLl 
activity was determined in the presence of different concentrations of NR, NMN, and 
Mg2+-complexed ATP. The Michaelis-Menten equation combined with a substrate inhibition model, 
or the Hill model [32] was fitted to the data. 
In measurements at constant ATP concentration (10 mM) the conversion of NR to NAD showed 
hyperbolic dependence on the NR concentration, but substrate inhibition was observed at high NR 
concentration. Analysis of the data using the Michaelis-Menten equation combined with a substrate 
inhibition model yielded Km = 0.6 ± 0.1 mM, Ki = 31.4 ± 8.1 mM and Vmax = 0.4 ± 0.1 µmol·min−1·mg−1 
(Figure 2A and Table 2). The same experiment was performed with a fixed NR concentration of 1 
mM, while varying the concentration of Mg-ATP. The Hill equation was fitted to the data, yielding 
Km = 5.2 ± 0.9 mM for ATP and Vmax of 0.4 ± 0.1 µmol·min−1·mg−1 with a Hill coefficient of 2.3 ± 0.5 
(Figure 2B and Table 3). The value of the Hill coefficient implies that more than one molecule of ATP 
is cooperatively involved in NR conversion by NadRLl protein. The apparent cooperativity could be 
caused by the two-step catalysis, in which ATP is used for conversion of both NR to NMN, and 
NMN to NAD. To test this possibility, we also performed kinetic measurements using NMN as the 
substrate, and thus only following the second step, the conversion of NMN to NAD. At constant 
ATP concentration (10 mM) and varying concentration of NMN (up to 5 mM), the conversion of 
NMN to NAD followed Michaelis-Menten kinetics with substrate inhibition, with Km = 0.5 ± 0.1 mM, 
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Ki = 25.4 ± 10.8 mM and Vmax of 1.5 ± 0.1 µmol·min−1·mg−1 for NMN (Figure 3A and Table 2). 
Previously a lower Km value for NMN conversion by the NadRHi protein was reported (0.14 mM) 
[21]. The discrepancy could be because the concentration of NMN used previously was varied only 
up to 1 mM with 0.2 mM of ATP present during that experiment. It could be that in these 
experimental conditions, the amount of ATP was limiting, but since no Km or Vmax values for ATP 
were reported, it is not possible to conclusively attribute the discrepancy to the ATP concentration. 
The differences could also simply reflect the unequal activity of NadR proteins from different 
organisms. The same experiment was performed using a fixed NMN concentration of 1 mM while 
varying the concentration of Mg-ATP up to 10 mM. The Hill equation was fitted to the data-yielding 
Km of 5.2 ± 0.6 mM, for ATP with Vmax of 1.2 ± 0.1 µmol·min−1·mg−1 and Hill coefficient of 2.2 ± 0.3 
(Figure 3B and Table 3). Again, the Hill coefficient is an indication that more than one molecule of 
ATP is utilized during NMN conversion, which is surprising because only a single ATP molecule is 
used in the reaction from NMN to NAD.  
Table 2. Apparent Km, Ki and Vmax values of the NadR-catalyzed reaction for nicotinamide 
mononucleotide (NMN) and nicotinamide riboside (NR) in presents of constant concentration ATP 
(10 mM). 
 Km, mM Vmax, µmol·min−1·mg−1 Ki, mM 
NR 0.6 ± 0.1 0.4 ± 0.1 31.4 ± 8.1 
NMN 0.5 ± 0.1 1.5 ± 0.1 25.4 ± 10.8 
The error is the standard derivations of the three independent measurements. 
 
Figure 2. Apparent Km and Vmax determination of NadR from L. lactis for the substrate nicotinamide 
riboside at the constant ATP concentration of 10 mM (A) and for ATP at the constant NR 
concentration of 1 mM (B). 
Table 3. Apparent Km, Vmax and the Hill coefficient values of NadR from L. lactis for ATP in the 
presence of a constant concentration of NR or NMN (1mM ). 
 Km, mM Vmax, µmol·min−1·mg−1 The Hill Coefficient 
NR 5.2 ± 0.9 0.4 ± 0.1 2.3 ± 0.5 
NMN 5.2 ± 0.6 1.2 ± 0.1 2.2 ± 0.3 
The error is the standard derivations of the three independent measurements. 
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Figure 3. Apparent Km and Vmax determination for substrates nicotinamide mononucleotide (at a 
constant ATP concentration of 10 mM) (A) and ATP (at a constant NMN concentration of 1 mM) (B). 
2.4. Dependence of the Kinetics of NAD Production on the NadRll Concentration 
To investigate further the reactions catalyzed by NadRLl, we measured kinetics with 1 mM NR 
as a substrate using two different concentrations of protein (0.1 mg·mL−1 and 1.0 mg·mL−1). An 
increase in absorbance at 340 nm from NADH production was measured during the time course of 
the reaction. With the lower protein concentration (0.1 mg·mL−1) we observed lag phase, which can 
be explained because the NadR protein first converts NR to NMN as an intermediate product, which 
accumulates to some extent; subsequently, the conversion of NMN to NAD takes place that results 
in an increase in absorbance. With the ten-fold higher protein concentration (1.0 mg·mL−1), we 
observed that reaction goes faster (Figure 4A), and there is no visible build-up phase meaning that 
the rate of NMN production is not limiting the second step. When the reaction with 0.1 mg·mL−1 
protein was allowed to run longer (more than 1 h), gradually, the amount of product reached almost 
the same level (Figure 4B). During this experiment, the LDH activity was not rate-limiting (data not 
shown).  
 
Figure 4. Time course of NADH formation with nicotinamide riboside as a substrate at two different 
protein concentrations (0.1 mg·mL−1 (black line) and 1.0 mg·mL−1 (red line), arrows indicate the 
addition of NadR) (A). Extended time scale (90 min) of the experiment with 0.1 mg·mL−1 (black line) 
(B). 
2.5. Oligomeric State of NadR 
Singh et al. [22], speculated that NadRHi may presumably work as a tetramer based on the 
crystal packing they observed in the structure of NadRHi. This idea was corroborated by analytical 
ultracentrifugation experiments; however, the results showed some heterogeneity in the mass of 
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complex [22]. A tetrameric arrangement creates a closed barrel with the cavity at the center and with 
the active sites of both domains (per monomer) facing away from the cavity [22]. To check the 
oligomeric state of NadRLl, we used Multiangle laser light scattering coupled to Size-exclusion 
chromatography (SEC-MALLS), as this technique has been successfully used to determine 
oligomeric states of proteins [33,34]. SEC-MALLS showed that NadRLl with and without substrates is 
a monomeric protein with an average mass of 47.3 kDa in solution (Figure 5A,B). Notably, the 
presence of the substrate affected the elution volumes. A possible explanation can be that protein 
without substrate is conformationally more flexible, while binding to substrate makes it more 
globular, which yields a delayed elution volume. 
 
Figure 5. Oligomeric state of the NadR protein from L. lactis in solution. SEC-MALLS analysis of 
NadR without substrates (A) and in the presence of 5 mM ATP and 1 mM NMN (B). 
2.6. Crystal Structures of NadR 
NadRLl crystallized in the P6422 space group with two molecules in the asymmetric unit. The 
structure was solved using the structure of NadRHi (PDB code: 1LW7) as an input for the molecular 
replacement. After several rounds of refinement intertwined with manual model building, the final 
NadRLl model was obtained (see Table 4 for the detailed statistics on data collection and refinement). 
Each molecule of NadRLl is comprised of two domains—an N-terminal NMNAT domain (residues 
8–177) folded in a Rossmann-like fold and a C-terminal RNK domain (residues 178–379) (Figure 6). 
In the previously reported NadRHi crystal structure, NAD was bound to the NMNAT domain; 
however, we did not observe NAD molecules bound to the NMNAT domain of NadRLl. The 
clamshell-like binding site was rather squeezed, and the nicotinamide recognition loop was open 
(Figure 6B). The ATP-binding site of the NMNAT domain was also distorted (Figure 6C), and we 
observed a bound sulfate ion at the position where the β- or γ-phosphate of ATP is expected to be 
located. The RNK domain also had no substrate bound, with the positions of essentially conserved 
side chains of Walker A (residues 187–195) and Walker B (residues 254–260) motifs (canonical motifs 
for ATP-binding) of NadRLl and NadRHi superimposing well (Figure 6C, also see Figure 1 for the 
sequence alignment). The lid region (residues 304–318) had fallen back into the binding site (Figure 
6C), thus, there is not enough space for binding of ATP or NR. 
Interestingly, we observed strong positive electron density in the region between the two 
domains whenever we added substrates for co-crystallization. In one of the collected datasets, we 
observed a mixture of NAD and AMP-PNP bound at this location in the electron density (Figure 6D 
and Supplementary Figure S2). Additionally, we obtained structures in the presence of NMN and 
NR, which both have bound substrates in a similar area. This novel ‘binding site’ is very different 
from the canonical binding sites in NMNAT and RNK domains and is formed by side chains of K65, 
Y69, R177, H178, Y240, S244, N248, and R293 (Figure 6D).  
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Figure 6. Crystal structure of NadRLl. (A) Overall fold in secondary structure cartoon representation, 
NMN adenylyltransferase (NMNAT) domain in red and ribosylnicotinamide kinase (RNK) domain 
in yellow; unresolved loops are shown as dashed lines. (B) Superposition of NadRLl with NadR from 
H. influenzae (cyan, the substrate from this structure is shown as sticks), the movements of the 
nicotinamide-recognition loop and one of the helixes forming the binding site are shown with red 
arrows; rmsd ~ 2.5 Å; (C) ATP-binding site in the RNK domain: the position of the lid loop is 
indicated within a dashed rectangle; a sulfate ion likely occupies the position of one of ATP 
phosphates; essentially conserved Lys and Asp residues of Walker A and B motifs are shown as 
sticks (numbering from NadRLl, with NadRHI numbers in brackets); (D) A possible binding site at the 
interface between the domains: NAD, AMP-PNP, and the protein residues forming this binding site 
are shown as sticks. The omit electron densities for these cofactors, as well as NR and NMN, are 
shown in Supplementary Figure S2. 
Table 4. Data collection and refinement statistics for the NadRLl crystal structures with respective 
substrates. 
 NadR NR NadR NMN NadR NAD AMP-PNP 
PDB code 
Data collection 
6GYE 6GYF 6GZO 
Space group P 64 2 2 P 64 2 2 P 64 2 2 
Unit cell dimensions    
a, b, c (Å) 165.14, 165.14, 196.55 165.09, 165.09, 193.05 167.32, 167.32, 192.81 
α, β, γ (°) 90.0, 90.0, 120.0 90.0, 90.0, 120.0 90.0, 90.0, 120.0 
Resolution range (Å) 
47.4–2.30  
(2.33–2.30)* 
47.83–2.70  
(2.76–2.70)* 
45.74–3.00  
(3.09–3.00)* 
Rmeas (%) 16.6 (>100)* 13.1 (>100)* 9.4 (>100) * 
cc1/2 99.8 (29.4)* 99.8 (33.0)* 99.8 (72.5) * 
I/σI 12.5 (0.9)* 11 (0.6)* 5.6 (1.7) * 
Completeness (%) 100 (100)* 100 (99.9)* 100 (99.4)* 
Multipilicity 13.5 (13.4)* 13.4 (13.1)* 6.5 (6.4)* 
Refinement    
Resolution (Å) 47.4–2.30 47.83–2.70 45.74–3.00 
No. of reflections 70441 41577 32439 
Rwork/Rfree 0.18/0.21 0.20/0.24 0.19/0.24 
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Number 
non-hydrogen atoms 
6446 6109 5993 
Protein 6084 6042 5838 
Ligands/Ions 36/60 44/23 88/5 
Water 266 0 0 
B-factors (Å2)    
Protein 70.9 86.5 118.8 
Ligand/Ions 109.7/115.1 98.6/101.1 135.9/178.3 
Water 67.1 – – 
R.m.s. deviations    
Bond lengths (Å) 0.008 0.009 0.009 
Bond angles (°) 0.958 1.054 1.275 
Molprobity score 1.83 2.08 2.56 
* for the highest resolution shell. 
3. Discussion 
NadR proteins can be involved in different functions: NAD biosynthesis and transcriptional 
regulation. While NadR proteins from Haemophilus sp and most Gram-negative bacteria contain a 
DNA binding domain at the N terminus, such a domain is absent in the NadRLl protein, indicating 
that NadRLl is not involved in transcriptional regulation. Here we provide a biochemical study of 
NadRLl along with crystal structures. We found sigmoidal dependence of the rate of NAD formation 
on the concentration of ATP, both for the conversion of NR to NAD and for the conversion of NMN 
to NAD. Whereas the sigmoidal behavior could be explained for the reaction in which NR is 
converted into NAD, because two molecules of ATP are used, the sigmoidal behavior is unexpected 
for the conversion of NMN. There is possibly a regulatory site where ATP binds. The positive 
electron density between the two domains observed in the crystal structure could be such a site.  
We solved crystal structures of NadRLl in the presence of various substrates. The only available 
crystal structure of NadRHi contains bound NAD in both the domains. Here we observed electron 
density for an NAD or other nucleotide molecule at a different site, located between the two 
domains, whereas the predicted active sites were unoccupied. Although we cannot completely rule 
out that the new binding site is an artifact of crystallization, another explanation is that this site is a 
transfer hub between two domains. After the RNK domain has performed phosphorylation of 
nicotinamide riboside to produce NMN, the latter molecule has to be transported to the NMNAT 
domain, where the consequent conversion into NAD takes place. Such a depot site might be of use to 
temporarily keep an intermediate substrate to prevent its diffusion away from the protein. The site 
may also have a function for allosteric regulation, which could explain the sigmoidal dependence of 
the conversion of NMN to NAD on the ATP concentration. 
4. Materials and Methods 
4.1. Cloning 
The gene encoding NadRLl was cloned in the p2BAD vector [35] using the restriction sites Sac1 
and Kas1 with the sequence coding for an N-terminal twin strep tag 
(WSHPQFEK-(GGGS)2-GGS-SA-WSHPQFEK) downstream of the second promotor. The plasmid 
was transformed into competent cells of the E. coli strain MC1061. 
4.2. Protein Expression and Purification  
Protein overexpression was done in the E. coli MC1061 strain transformed with the expression 
plasmid. Cells were cultivated in five-liter flasks containing 2 L luria bertani (LB) medium with the 
composition of 10 g NaCl, 10 g Tryptone, and 5 g yeast extract per liter. The E. coli cells with p2BAD 
plasmid were grown at 37 °C, 200 rpm to an OD600 of 0.6. Once the OD reached 0.6, induction was 
done with 0.04% arabinose. After induction, cells were grown further for another 3 h at 37 °C. After 3 
Molecules 2020, 25, 1940 10 of 14 
 
h of induction, cells were collected by centrifugation (20 min, 7,446 g, 4 °C), washed in wash buffer 
(50 mM Tris/HCl, pH 7.5) and resuspended in the buffer A (50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 
and 10% glycerol). Cells were lysed by high-pressure disruption (Constant Cell Disruption System 
Ltd., Northamptonshire UK, one passage at 25 kPsi for E. coli cells at 5 °C). After cell lysis, 1 mM 
MgSO4, 0.2 mM PMSF, and 50–100 mg·mL−1 DNase were added. Cell debris was removed by 
low-speed centrifugation (20 min, 12,074 g, 4 °C). To remove crude membranes and other impurities, 
the supernatant was centrifuged for 45 min, 193727 g, 4 °C. The clear supernatant was used for 
further protein purification. 
The clear supernatant was passed through a streptavidin resin column (total volume 1 mL), 
which was pre-equilibrated with buffer B (50 mM Tris/HCl, pH 8.0 and 1 mM EDTA). The 
flow-through was collected for SDS gel electrophoresis. Once supernatant was passed, the column 
material was washed with 20 CV of wash buffer C (50 mM Tris/HCl pH 8.0, 200 mM NaCl, 1 mM 
EDTA). NadR was eluted in three fractions (E1, E2 and E3) of 350, 750 and 600 µL respectively with 
elution buffer D (50 mM Tris/HCl pH 8.0, 150 mM NaCl, 1 mM EDTA and 1 mM des-thiobiotine). 
Elution fraction E2 contained the highest amount of protein as measured by absorbance at 280 nm 
using a nanodrop machine. This fraction was further purified by size-exclusion chromatography 
with column Superdex 200, 10/300 gel filtration column (GE Healthcare), equilibrated with buffer E 
(50 mM Tris/HCl pH 8.0, 150 mM NaCl). 
After size-exclusion chromatography, the fractions containing the NadR protein were 
combined and used directly for ITC and kinetics measurements. For crystallization, the protein was 
concentrated with a vivaspin 500 concentrator with a molecular weight cutoff of 30 kDa (Sartorius 
stedim), to a final concentration of 17 mg·mL−1. 
4.3. Isothermal Calorimetric Titration (ITC) Measurements for Substrate Specificity 
ITC measurements were conducted with an ITC200 calorimeter (MicroCal, Malvern, UK) at 25 
°C. The substrates nicotinamide riboside (Niagen TM, Chromadex, Los Angeles, CA, USA), NMN 
(Sigma Aldrich, St. Louis, MO, USA), NAD (Sigma Aldrich, St. Louis, MO, USA) and nicotinamide 
were dissolved in the buffer that was used for protein purification. The substrate concentration used 
for ITC measurements varied from 1 mM to 5 mM as a final concentration. The ligand solutions were 
added into the temperature-equilibrated ITC cell filled with 300 µL of protein with a concentration 
of 10–50 µM. The final obtained data were analyzed with ORIGIN-based software (MicroCal). 
4.4. Lactate Dehydrogenase (LDH) Coupled NADH Measurements Assay  
NadRLl kinetics was assayed using lactate dehydrogenase (LDH) coupled NADH 
measurements using an Agilent spectrophotometer (Cary 100 UV-Vis) with a quartz cuvette. The 
measurements were done by varying the concentration of NR, in the reaction buffer F (100 mM 
Tris/HCl pH 7.5) containing 10 mM Mg-ATP, 150 mM lactic acid, 10 µL (10 mg·mL−1, 550 units/mg) 
of LDH and NadRLl protein with a concentration of 1.0 mg·mL−1, with a final volume of 200 µL. The 
same reaction was also performed, by varying the concentration of Mg-ATP (up to 10 mM) while 
keeping NR concentration constant at 1 mM in the presence of 150 mM lactic acid, 10 µL (10 
mg·mL−1, 550 units/mg) of LDH and 1.0 mg·mL−1 of NadRLl protein in the buffer F with the final 
volume of 200 µL. For NMN measurements, we varied the concentration up to 5 mM, and we used 
10 mM Mg-ATP, 150 mM lactic acid, 10 µL (10 mg·mL−1, 550 units/mg) of LDH, and 1.0 mg·mL−1 
NadRLl protein in the buffer F with the same reaction volume of 200 µL. The reaction was further 
studied with the fixed amount of NMN (1 mM) and varying Mg-ATP concentrations, as described 
for NR. The reaction was started by the addition of NadR protein to all other pre-mixed components 
(incubated at 25 °C for 1 min), and NADH absorbance was measured at a wavelength of 340 nm. As 
controls, each component was removed one by one (with the appropriate volume compensation by 
addition of buffer) during the kinetics measurements. 
The specific enzyme activity was calculated by using the formula, as shown below 
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where:      is initial specific activity (µmol·min−1·mg−1);    is the initial slope of increase in 
absorbance (min−1);      is total reaction volume (µL);      is added diluted enzyme volume (µL);   
is protein stock concentration (mg·mL−1). 
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inhibition was observed) Michaelis-Menten equations 
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where:    is initial specific activity measured in initial step of reaction (µmol·min−1·mg−1);      is 
maximal possible specific rate of reaction (µmol·min−1·mg−1);   is substrate concentration (mM);     
is michaelis-Menten constant (mM);     is substrate inhibition concentration (mM). 
The hill fitting parameters were calculated using the following equation 
   =
      ×   
 
  
  +   
 (3) 
where   is the hill coefficient. 
Origin Pro v8.0724 Software (OriginLab Corporation) was used for the non-linear fitting of data 
according to this equation. 
4.5. Crystallization 
The initial crystallization trials were done with the commercial screens such as MCSG 
(Microlytic, Burlington, MA, USA) and Membrane Gold (Molecular Dimensions, Sheffield, UK) 
using the mosquito crystallization robot (TPP LabTech, Melbourne, UK). Initial crystals were 
obtained at 4 °C, but the diffraction was limited to 7–10 Å resolution. After the first round of 
optimization, we improved the diffraction up to 5 Å resolution. Further optimizations were set up as 
vapor-diffusion sitting drops (1:1 ratio, 0.1 µL) at 16 °C with the protein concentration of 17 mg·mL−1. 
Diamond-shaped crystals were obtained within 3–5 days. These crystals diffracted to around 3 Å 
resolution. As the final optimization, the additive screen (Hampton Research) was used to obtain the 
crystals with the diffraction limit of 2–3 Å resolution. The crystallization conditions were as follows: 
1 M (NH4)2SO4, 100 mM Na Citrate pH 6.5, 10 mM MgCl2 and 10% glucose or 1 M (NH4)2SO4, 100 
mM Hepes pH 7.0 and 10% CaCl2. Co-crystallization with NR, NMN, NAD, Mg-ATP, and with 
Mg-AMP-PNP was performed. In the NR-bound state, the co-crystallization condition was 1 M 
(NH4)2SO4, 100 mM Na Citrate pH 6.5, 5 mM NR, 10 mM MgCl2, and 10% glucose. In NMN bound 
co-crystallization condition, all the components mentioned above remained the same except NR was 
replaced by the addition of 5 mM NMN. The NAD bound co-crystallization condition also remained 
the same with an addition of 5 mM NAD along with 5 mM Mg-AMP-PNP. All the crystals were 
flash-frozen in liquid nitrogen for further X-ray diffraction analysis. 
4.6. Static Light Scattering and Refractive Index Measurements  
The determination of the oligomeric state of purified NadRLl was performed as described 
[33,34]. Briefly, the Superdex 200 column used for the SEC-MALLS analysis was equilibrated with 
SEC buffers (50 mM Tris/HCl, pH 8.0, 150 mM NaCl or 50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 5 
mM ATP, 1 mM NMN, filtered through 0.1 µm pore size VVLP filters (Millipore)), and subsequently 
the buffer was recirculated through the system for 16 h at 0.5 mL/min. Purging of the refractometer 
was switched off when the baselines were stable, and the detector reading was set to zero. 200 µL of 
protein solutions (0.5 mg·mL−1) with and without substrates accordingly were injected, and the data 
from the three detectors were imported by the ASTRA software package (Wyatt Technologies, Santa 
Barbara, CA, USA). The experiments were done at room temperature, but the differential 
refractometer was precisely set at 30 °C. 
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4.7. Data Collection, Structure Determination, and Refinement  
The diffraction data were collected at 100 K at the PX beamline at SLS (Villigen, Switzerland) 
and at the beamline ID29 (ESRF, Grenoble, France). Collected data were processed with XDS 
package [36]. Molecular replacement was performed with Phaser [37] using NadR from H. influenzae 
(PDB code 1LW7) as a starting model. Refinement was performed in Phenix [38] with the manual 
corrections in Coot [39]. The composite omit maps were calculated using simulated annealing 
protocol implemented in Phenix [38]. The final models were deposited in PDB databank under 
6GYE for NadR with NR, 6GYF for NadR with NMN, and 6GZO for NadR with NAD/AMP-PNP. 
Supplementary Materials: The following are available online, Figure S1: Schematic representation of NadR 
catalytic reaction, Figure S2: The composite omit electron density for (A) NR (contoured at 1) (B) NMN 
(contoured at 1.5) and (C) mixture of NAD and AMP-PNP (contoured at 1). 
Author Contributions: Conceptualization: M.J., D.J.S. with contribution from all authors; methodology and 
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